AR and metabolic dysfunction-associated steatohepatitis: Taken together, our findings in clinical HCC specimens consolidate our model of IL-6-triggered self-reinforcing STAT3/AR/CCRK circuitry, thereby activating mTORC1 signaling cascades to promote NASH-associated HCC development (Fig. 7d).